These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 16424007)
1. Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer. Balasubramani M; Day BW; Schoen RE; Getzenberg RH Cancer Res; 2006 Jan; 66(2):763-9. PubMed ID: 16424007 [TBL] [Abstract][Full Text] [Related]
2. Heterogenous nuclear ribonucleoprotein F modulates angiotensinogen gene expression in rat kidney proximal tubular cells. Wei CC; Guo DF; Zhang SL; Ingelfinger JR; Chan JS J Am Soc Nephrol; 2005 Mar; 16(3):616-28. PubMed ID: 15659559 [TBL] [Abstract][Full Text] [Related]
3. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Engelhardt M; Drullinsky P; Guillem J; Moore MA Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582 [TBL] [Abstract][Full Text] [Related]
4. [Screening human gastric carcinoma-associated antigens by serologic proteome analysis]. Zeng X; Liao AJ; Tang HL; Yi L; Xie N; Su Q Ai Zheng; 2007 Oct; 26(10):1080-4. PubMed ID: 17927877 [TBL] [Abstract][Full Text] [Related]
5. Heterogeneous nuclear ribonucleoproteins F and H/H' show differential expression in normal and selected cancer tissues. Honoré B; Baandrup U; Vorum H Exp Cell Res; 2004 Mar; 294(1):199-209. PubMed ID: 14980514 [TBL] [Abstract][Full Text] [Related]
6. Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker. Huddleston HG; Wong KK; Welch WR; Berkowitz RS; Mok SC Gynecol Oncol; 2005 Jan; 96(1):77-83. PubMed ID: 15589584 [TBL] [Abstract][Full Text] [Related]
7. Identification of nuclear matrix protein alterations associated with human colon cancer. Brünagel G; Vietmeier BN; Bauer AJ; Schoen RE; Getzenberg RH Cancer Res; 2002 Apr; 62(8):2437-42. PubMed ID: 11956108 [TBL] [Abstract][Full Text] [Related]
8. Colon cancer specific nuclear matrix protein alterations in human colonic adenomatous polyps. Brünagel G; Schoen RE; Getzenberg RH J Cell Biochem; 2004 Feb; 91(2):365-74. PubMed ID: 14743395 [TBL] [Abstract][Full Text] [Related]
9. Identification of calreticulin as a nuclear matrix protein associated with human colon cancer. Brünagel G; Shah U; Schoen RE; Getzenberg RH J Cell Biochem; 2003 May; 89(2):238-43. PubMed ID: 12704787 [TBL] [Abstract][Full Text] [Related]
10. Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression. Greco C; Alvino S; Buglioni S; Assisi D; Lapenta R; Grassi A; Stigliano V; Mottolese M; Casale V Anticancer Res; 2001; 21(5):3185-92. PubMed ID: 11848471 [TBL] [Abstract][Full Text] [Related]
11. Altered gene expression in normal colonic mucosa of individuals with polyps of the colon. Hao CY; Moore DH; Chiu YS; Wong P; Bennington JL; Smith AP; Chen LC; Lee NM Dis Colon Rectum; 2005 Dec; 48(12):2329-35. PubMed ID: 16400515 [TBL] [Abstract][Full Text] [Related]
12. Increased creatine kinase BB activity and CKB mRNA expression in patients with hematologic disorders: relation to methylation status of the CKB promoter. Ishikawa J; Taniguchi T; Takeshita A; Maekawa M Clin Chim Acta; 2005 Nov; 361(1-2):135-40. PubMed ID: 15996648 [TBL] [Abstract][Full Text] [Related]
13. Editing of hnRNP K protein mRNA in colorectal adenocarcinoma and surrounding mucosa. Klimek-Tomczak K; Mikula M; Dzwonek A; Paziewska A; Karczmarski J; Hennig E; Bujnicki JM; Bragoszewski P; Denisenko O; Bomsztyk K; Ostrowski J Br J Cancer; 2006 Feb; 94(4):586-92. PubMed ID: 16404425 [TBL] [Abstract][Full Text] [Related]
14. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer. Zech VF; Dlaska M; Tzankov A; Hilbe W Cancer Detect Prev; 2006; 30(5):395-402. PubMed ID: 17067748 [TBL] [Abstract][Full Text] [Related]
15. A proteomic profile of washing fluid from the colorectal tract to search for potential biomarkers of colon cancer. Giusti L; Iacconi P; Da Valle Y; Ciregia F; Ventroni T; Donadio E; Giannaccini G; Chiarugi M; Torregrossa L; Proietti A; Basolo F; Lucacchini A Mol Biosyst; 2012 Apr; 8(4):1088-99. PubMed ID: 22294321 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of telomerase in the development and progression of colon cancer. Boldrini L; Faviana P; Gisfredi S; Zucconi Y; Di Quirico D; Donati V; Berti P; Spisni R; Galleri D; Materazzi G; Basolo F; Miccoli P; Pingitore R; Fontanini G Int J Mol Med; 2002 Nov; 10(5):589-92. PubMed ID: 12373297 [TBL] [Abstract][Full Text] [Related]
17. Prognostic and predictive potential molecular biomarkers in colon cancer. Nastase A; Pâslaru L; Niculescu AM; Ionescu M; Dumitraşcu T; Herlea V; Dima S; Gheorghe C; Lazar V; Popescu I Chirurgia (Bucur); 2011; 106(2):177-85. PubMed ID: 21696062 [TBL] [Abstract][Full Text] [Related]
18. Expression of a highly conserved oncofetal gene, TA1/E16, in human colon carcinoma and other primary cancers: homology to Schistosoma mansoni amino acid permease and Caenorhabditis elegans gene products. Wolf DA; Wang S; Panzica MA; Bassily NH; Thompson NL Cancer Res; 1996 Nov; 56(21):5012-22. PubMed ID: 8895758 [TBL] [Abstract][Full Text] [Related]
19. Clinical implications of fibroblast activation protein in patients with colon cancer. Henry LR; Lee HO; Lee JS; Klein-Szanto A; Watts P; Ross EA; Chen WT; Cheng JD Clin Cancer Res; 2007 Mar; 13(6):1736-41. PubMed ID: 17363526 [TBL] [Abstract][Full Text] [Related]
20. Identification of proteins from colorectal cancer tissue by two-dimensional gel electrophoresis and SELDI mass spectrometry. Melle C; Osterloh D; Ernst G; Schimmel B; Bleul A; von Eggeling F Int J Mol Med; 2005 Jul; 16(1):11-7. PubMed ID: 15942672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]